Vantage Foundation Joins The Habbit Factory to Empower Young Voices Through Creative Confidence
LONDON, June 12, 2025 /PRNewswire/ -- Vantage Foundation is proud to support…
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…